Evidence map›Paper›PMID 40559610›Full record

ArticlePathogens (Basel, Switzerland)2025

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis.

Tomasz Bogiel, Edyta Dolska, Małgorzata Zimna, Kornelia Nakonowska, Dorota Krawiecka, Renata Żebracka, Maciej Pochowski, Agnieszka Krawczyk

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomasz BogielDepartment of Propaedeutics of Medicine and Infection Prevention Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.ORCID 0000-0001-6787-1378
Edyta DolskaDepartment of Microbiological Diagnostics, Kujawsko-Pomorskie Pulmonology Centre in Bydgoszcz, 85-326 Bydgoszcz, Poland.
Małgorzata ZimnaDepartment of Microbiological Diagnostics, Kujawsko-Pomorskie Pulmonology Centre in Bydgoszcz, 85-326 Bydgoszcz, Poland.
Kornelia NakonowskaDepartment of Microbiological Diagnostics, Kujawsko-Pomorskie Pulmonology Centre in Bydgoszcz, 85-326 Bydgoszcz, Poland.
Dorota KrawieckaDepartment of Microbiological Diagnostics, Kujawsko-Pomorskie Pulmonology Centre in Bydgoszcz, 85-326 Bydgoszcz, Poland.
Renata ŻebrackaDepartment of Microbiological Diagnostics, Kujawsko-Pomorskie Pulmonology Centre in Bydgoszcz, 85-326 Bydgoszcz, Poland.
Maciej PochowskiDepartment of Microbiological Diagnostics, Kujawsko-Pomorskie Pulmonology Centre in Bydgoszcz, 85-326 Bydgoszcz, Poland.
Agnieszka KrawczykDepartment of Molecular Medical Microbiology, Chair of Microbiology, Jagiellonian University Medical College, 31-121 Kraków, Poland.ORCID 0000-0002-9719-9663

Funding

Nicolaus Copernicus University WF PDB 839
6 · The paper itself

Abstract

Tuberculosis (TB), primarily caused by

Indexed as

Drug Resistance, Multiple, BacterialMolecular Diagnostic TechniquesMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsDNA, BacterialHumansIsoniazidMicrobial Sensitivity TestsMutationReal-Time Polymerase Chain ReactionRifampinSensitivity and SpecificityAntitubercular AgentsDNA, BacterialIsoniazidRifampinBD MAX MDR-TBisoniazidmultidrug-resistant tuberculosisMycobacterium tuberculosis complexrifampicintuberculosis

Identifiers

PMID40559610
PMCPMC12195635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.